Contrast‐Enhanced Ultrasound in Patients With COVID‐19
Pneumonia, Acute Respiratory Distress Syndrome, or Something Else?
May 12, 2020 — Journal of Ultrasound in Medicine
Coronavirus disease 2019 spiepr132 (COVID‐19) represents a very heterogeneous disease. Some aspects of spiepr132 COVID‐19spiepr132 pneumonia question the real nature of ground glass opacities and its consolidative lesions. It has been hypothesized that spiepr132 COVID‐19spiepr132 lung involvement could represent not only a viral effect but also an immune response induced by the infection, causing epithelial/endothelial lesions and coagulation disorders. We report 3spiepr146 cases of spiepr132 COVID‐19spiepr132 pneumonia in which spiepr132 contrast‐enhancedspiepr132 ultrasound was suggestive of consolidations with perfusion defects, at least in part caused by ischemic or necrotic changes and not only by inflammatory or atelectasis events.
Authors: Gino Soldati, MD1, Gianfranco Giannasi, MD2, Andrea Smargiassi, MD, PhD3ID, Riccardo Inchingolo, MD3ID, Libertario Demi, PhD*4ID
1 Diagnostic and Interventional Ultrasound Unit, Valle del Serchio General Hospital, Lucca, Italy; 2 Emergency Medicine Unit, San Giovanni di Dio Hospital, Florence, Italy; 3 Pulmonary Medicine Unit, Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy; 4 Department of Information Engineering and Computer Science, Ultrasound Laboratory Trento, University of Trento, Trento, Italy
Full text available at: https://onlinelibrary.wiley.com/doi/10.1002/jum.15338